I. Introduction
This case is about a 32 year old multiparous who attended emergency with complains of 2-3 episodes of vomiting.She was pregnant by 8 months.Clinical examination did not reveal any significant abnormality except for mild tenderness in the epigastric region.Routine investigations were within reference range.The Gynaecologist treated the case as of gastritis with I.V pantoprazole and I.V ondansetron.The condition of the patient deteriorated next day morning when she developed 7 episodes of convulsions.Immediate termination of pregnancy was advised.During the intraoperative period,the condition of the patient further deteriorated due to severe bleeding without any injury to major vessels.Blood sample was sent for further investigations which revealed a very low haemoglobin (2gm%),elevated liver enzymes with elevated bilirubin ( T.Bil -2.1mg% ,D Bil -1mg%,SGOT -4600 IU/l,SGPT -5400 IU/l,ALP-880 IU/l) and a very low platelet count ( less than 16,000/cumm).Serum LDH was also very high and gross proteinuria was present.The case was diagnosed to be a case of HELLP syndrome and treated accordingly and luckily the patient survived.
This variable nature of clinical presentation generally delays the diagnosis of HELLP syndrome for an average of 8 days (1) .Patients with this disorder are often misdiagnosed with other disorder such as cholecystitis,esophagitis, gastritis,hepatitis or ITP. (2) HELLP syndrome named for three features like hemolysis,elevated liver enzymes and low platelet count is life threatening condition that can potentially complicate pregnancy.Although some propose that HELLP syndrome is a severe form of Pre-eclampsia,others believe that HELLP syndrome is an entity of its own (3) . HELLP syndrome occurs in 0.1%-0.6% of all pregnancies and in 4%-12% of patients with preeclampsia. Multiparity,maternal age greater than 35 years,white race and history of poor pregnancy outcome are the known associated risk factors (4) . The pathophysiology of HELLP syndrome is ill defined.Probably it starts from defective placental vascular remodelling during 16-22wks of gestation,resulting in release of placental factors such as Soluble Vascular Endothelial Growth Factor Receptor -1 (SVEGR-1) and placental growth factor which binds vasculoendothelial growth factor(VEGF).This prevents the growth factors to bind to the endothelial cell receptors, resulting in endothelial and placental dysfunction (5) .The coagulation cascade gets activated,resulting in consumption of platelets due to adhesion into a damaged and activated endothelium.The erythrocytes also get destroyed as they traverse through the capillaries laden with platelet fibrin deposits leading to microangiopathic haemolytic anaemia. Several other hypothesis includes acute maternal immune rejection due to immunocompetent maternal cells coming in contact with genetically distinct fetus altering the immune balance and causing endothelial dysfunction,platelet activation and aggregation and hypertension (6, 7, 8) . The vague presentation in HELLP syndrome in patients with nausea,vomiting, malaise,headache prevents the early diagnosis of the disease process.
Diagnostic tests of this condition includes decreased haptoglobin level to detect the ongoing haemolysis,raised transaminases level,low to very low platelet count. Also a positive D-dimer test is most sensitive indicator of subclinical coagulopathy and may be positive before coagulation studies are abnormal.
Prompt recognition of HELLP syndrome and timely initiation of treatment are vital to ensure favourable maternal and fetal outcome. The recurrence rate is 2%-27% in subsequent pregnancies (9, 10) .Patients with HELLP syndrome should be educated on the risk of maternal and fetal morbidity and mortality in future pregnancies.
